• Diagnostics Platforms
• Diagnostics Products

Strategic Alliance with Abbott in Molecular Diagnostics

Developing business with profit sharing arrangement End-user sales growth of 28.9% in fiscal 2006 versus prior year Recently introduced new products in U.S. and Europe Seeking global registration for key products Other new products in development View Celera's diagnostic products. View Celera's diagnostic platforms.

Celera's Discoveries and Products

From our genomics platform New molecular diagnostics and pharmacogenomic tests in development Novel findings with therapeutic and pharmacogenomic value Genetically validated druggable targets Unexploited indications for existing drugs Pharmacogenomic markers that predict therapy response From our proteomics platform Cancer targets Seven targets moving forward for therapeutic antibody development with partners Additional partnerships expected Diagnostic value View partnering opportunities in pharmacogenomics. View partnering opportunities in proteomics.